Early stage glioblastoma: retrospective multicentric analysis of clinical and radiological features.


Journal

La Radiologia medica
ISSN: 1826-6983
Titre abrégé: Radiol Med
Pays: Italy
ID NLM: 0177625

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 02 01 2021
accepted: 12 07 2021
pubmed: 3 8 2021
medline: 19 11 2021
entrez: 2 8 2021
Statut: ppublish

Résumé

The aim of this study was to report our experience with early stage glioblastoma (e-GB) and to investigate the possible clinical and imaging features that may be helpful to the radiologist to correctly diagnose this entity. We performed a retrospective research of patients diagnosed with glioblastoma at two hospitals during a 10-year period. We reviewed all pre-operative MR and included only patients with early stage GB lesions, characterized by hyperintense on T2-weighted signal, with or without contrast-enhancement at post-contrast T1-weighted images, without "classic" imaging appearance of GB (necrosis, haemorrhage, oedema). All preoperative MR were evaluated by an experienced neuroradiologist and information on patients' demographics, clinical presentation, follow-up, and histopathology results study were collected. When available, preoperative CT examination was also evaluated. We found 14 e-GBs in 13 patients (9 males, 4 females, median age 63 years) among 660 patients diagnosed with GB between 2010 and 2020. In 10 lesions, serial imaging revealed the transformation of e-GB in classic glioblastoma in a median time of 3 months. Clinical presentation included stroke-like symptoms, vertigo, seizures and confusion. Preoperative plain CT was performed in 8/13 cases and in 7 e-GBs presented as a hyperdense lesion. Ten out of 14 lesions transformed in classic GB before surgical intervention or biopsy. All lesions revealed typical immunohistochemical pattern of primary glioblastoma. E-GB is a rare entity that can often lead to misdiagnosis. However, the radiologist should be aware of its imaging appearance to suggest the diagnosis and to request close imaging follow-up, hopefully improving the prognosis of this very aggressive disease.

Identifiants

pubmed: 34338949
doi: 10.1007/s11547-021-01401-4
pii: 10.1007/s11547-021-01401-4
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1468-1476

Informations de copyright

© 2021. Italian Society of Medical Radiology.

Références

Wesseling P, Capper D (2018) WHO 2016 Classification of gliomas. Neuropathol Appl Neurobiol 44:139–150. https://doi.org/10.1111/nan.12432
doi: 10.1111/nan.12432 pubmed: 28815663
Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. https://doi.org/10.1007/s00401-016-1545-1
doi: 10.1007/s00401-016-1545-1 pubmed: 27704282 pmcid: 5481163
Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455(7216):1061–1068. https://doi.org/10.1038/nature07385
doi: 10.1038/nature07385
Montemurro N (2020) Glioblastoma Multiforme and genetic mutations: the issue is not over yet. An overview of the current literature. J Neurol Surg A Cent Eur Neurosurg 81(1):64–70. https://doi.org/10.1055/s-0039-1688911
Guerin JB, Eckel LJ, Kaufmann TJ (2016) Updates to the WHO Brain Tumor Classification System: What the Radiologist needs to know. RadioGraphics 37:2164–2180. https://doi.org/10.1148/rg.2017170037
doi: 10.1148/rg.2017170037
Jung T-Y, Jung S (2007) Early neuroimaging findings of glioblastoma mimicking non-neoplastic cerebral lesion. Neurol Med Chir (Tokyo) 47:424–427. https://doi.org/10.2176/nmc.47.424
doi: 10.2176/nmc.47.424
Nam TS, Choi KH, Kim MK, Cho KH (2011) Glioblastoma mimicking herpes simplex encephalitis. J Korean Neurosurg Soc 50(2):119–122.  https://doi.org/10.3340/jkns.2011.50.2.119
Thaler PB, Yi J, Isakov Y et al (2012) Normal or non-diagnostic neuroimaging studies prior to the detection of malignant primary brain tumors. J Clin Neurosci 19:411–414. https://doi.org/10.1016/j.jocn.2011.09.002
doi: 10.1016/j.jocn.2011.09.002 pubmed: 22277560
Oyama H, Ando Y, Aoki S et al (2010) Glioblastoma detected at the initial stage in its developmental process. Neurol Med Chir 50:414–417. https://doi.org/10.2176/nmc.50.414
doi: 10.2176/nmc.50.414
Ideguchi M, Kajiwara K, Goto H, Sugimoto K (2015) MRI findings and pathological features in early-stage glioblastoma. J Neurooncol. https://doi.org/10.1007/s11060-015-1797-y
doi: 10.1007/s11060-015-1797-y pubmed: 25939441
Toh CH, Castillo M (2017) Early-stage Glioblastomas: MR Imaging-based classification and imaging evidence of progressive growth. AJNR Am J Neuroradiol 38:288–293. https://doi.org/10.3174/ajnr.A5015
doi: 10.3174/ajnr.A5015 pubmed: 27856439 pmcid: 7963843
Larjavaara S, Mäntylä R, Salminen T et al (2007) Incidence of gliomas by anatomic location. Neuro Oncol 9:319–325. https://doi.org/10.1215/15228517-2007-016
doi: 10.1215/15228517-2007-016 pubmed: 17522333 pmcid: 1907421
Hishii M, Toshiharu M, Arai H (2019) Diagnosis and teatment of early-stage Glioblastoma. Asian J Neurosurg 14:589–592. https://doi.org/10.4103/ajns.AJNS_18_19
doi: 10.4103/ajns.AJNS_18_19 pubmed: 31143291 pmcid: 6516039
Cohen-Gadol AA, DiLuna ML, Bannykh SI et al (2004) Non-enhancing de novo glioblastoma: report of two cases. Neurosurg Rev 27:281–285. https://doi.org/10.1007/s10143-004-0346-5
doi: 10.1007/s10143-004-0346-5 pubmed: 15449198
Nishi N, Kawai S, Yonezawa T (2009) Early appearance of high grade Glioma on Magnetic Resonance Imaging. Neurol Med Chir 49:8–12. https://doi.org/10.2176/nmc.49.8
doi: 10.2176/nmc.49.8
Wang H, Liu Z, Zhang Y, Hou F, Fu W, Lin J, Liu Y, Liu X (2020) Additional diagnostic value of unenhanced computed tomography plus diffusion-weighted imaging combined with routine magnetic resonance imaging findings of early-stage gliblastoma. Biomed Res Int 2020:1672736. https://doi.org/10.1155/2020/1672736
Nishi N, Kawai S, Yonezawa T, Fujimoto K, Masui K (2009) Early appearance of high grade glioma on magnetic resonance imaging. Neurol Med Chir (Tokyo) 49(1):8–12. https://doi.org/10.2176/nmc.49.8
Rossi R, Figus A, Corraine S (2010) Early presentation of de novo high grade glioma with epileptic seizures: Electroclinical and neuroimaging findings. Seizure 19:470–474. https://doi.org/10.1016/j.seizure.2010.07.001
doi: 10.1016/j.seizure.2010.07.001 pubmed: 20674398
Zhang YY, Ruan LX, Zhang S (2016) Rapid progression of glioblastoma multiforme: a case report. Oncol Lett 12(6):4803–4806. https://doi.org/10.3892/ol.2016.5228
Hong EK, Choi SH, Shin DJ et al (2018) Radiogenomics correlation between MR imaging features and major genetic profiles in glioblastoma. Eur Radiol 28(10):4350–4361. https://doi.org/10.1007/s00330-018-5400-8
Hu LS, Ning S, Eschbacher JM et al (2017) Radiogenomics to characterize regional genetic heterogeneity in glioblastoma. Neuro-Oncology 19:128–137. https://doi.org/10.1093/neuonc/now135
doi: 10.1093/neuonc/now135 pubmed: 27502248
Ellingson BM (2015) Radiogenomics and imaging phenotypes in glioblastoma: novel observations and correlation with molecular characteristics. Curr Neurol Neurosci Rep 15(1):506. https://doi.org/10.1007/s11910-014-0506-0
Baehring JM, Bi WL, Bannykh S et al (2007) Diffusion MRI in the early diagnosis of malignant glioma. J Neurooncol 82:221–225. https://doi.org/10.1007/s11060-006-9273-3
doi: 10.1007/s11060-006-9273-3 pubmed: 17029014
Utsuki S, Oka H, Miyajima Y et al (2012) Glioblastoma without remarkable contrast enhancement on Magnetic Resonance Imaging. Int J Clin Med 03:439–445. https://doi.org/10.4236/ijcm.2012.36082
doi: 10.4236/ijcm.2012.36082
Koeller KKHJ (2001) From the archives of the AFIP: superficial gliomas: radiologic-pathologic correlation. Radiographics 21:1533–1536. https://doi.org/10.1148/rg.246045146
doi: 10.1148/rg.246045146 pubmed: 11706224
Friedman E (2014) Epilepsy imaging in adults: getting it right. Am J Roentgenol 203:1093–1103. https://doi.org/10.2214/AJR.13.12035
doi: 10.2214/AJR.13.12035
Kim SE, Lee BI, Shin KJ et al (2017) Characteristics of seizure-induced signal changes on MRI in patients with first seizures. Seizure 48:62–68. https://doi.org/10.1016/j.seizure.2017.04.005
doi: 10.1016/j.seizure.2017.04.005 pubmed: 28419949
Allen LM, Hasso AN, Handwerker J, Farid H (2012) Sequence-specific MR imaging findings that are useful in dating ischemic stroke. Radiographics 32:1285–1297. https://doi.org/10.1148/rg.325115760
doi: 10.1148/rg.325115760 pubmed: 22977018
Landy HJ, Lee TT, Potter P et al (2000) Early MRI findings in high grade glioma. J Neurooncol 47:65–72. https://doi.org/10.1023/A:1006494604527
doi: 10.1023/A:1006494604527 pubmed: 10930102
Yamaguchi S, Kobayashi H, Terasaka S et al (2012) The impact of extent of resection and histological subtype on the outcome of adult patients with high-grade gliomas. Jpn J Clin Oncol 42:270–277. https://doi.org/10.1093/jjco/hys016
doi: 10.1093/jjco/hys016 pubmed: 22399670
Stark AM, Van De BJ, Hedderich J et al (2012) Glioblastoma: clinical characteristics, prognostic factors and survival in 492 patients. Clin Neurol Neurosurg 114:840–845. https://doi.org/10.1016/j.clineuro.2012.01.026
doi: 10.1016/j.clineuro.2012.01.026 pubmed: 22377333
Jovčevska I (2019) Genetic secrets of long-term glioblastoma survivors. Bosn J Basic Med Sci 19(2):116–124. https://doi.org/10.17305/bjbms.2018.3717
Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F et al (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190–198. https://doi.org/10.3171/jns.2001.95.2.0190
doi: 10.3171/jns.2001.95.2.0190 pubmed: 11780887
Sanai N, Polley MY, McDermott MW, Parsa ATBM (2011) An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 115:3–8. https://doi.org/10.3171/2011.2.jns10998
doi: 10.3171/2011.2.jns10998 pubmed: 21417701
Hammoud MA (1996) Prognostic significance of preoperative MRI scans in glioblastoma multiforme. J Neurooncol 27:65–73. https://doi.org/10.1007/BF00146086
doi: 10.1007/BF00146086 pubmed: 8699228

Auteurs

Isabella Ceravolo (I)

Department of Neuroradiology, San Camillo Forlanini Hospital, Rome, Italy. ceravolo.isabella@gmail.com.

Giovanni Barchetti (G)

Department of Neuroradiology, San Bortolo Hospital, Vicenza, Italy.

Francesco Biraschi (F)

Department of Neurology and Psychiatry, Interventional Neuroradiology, Università degli Studi La Sapienza, Rome, Italy.

Carmela Gerace (C)

Department of Neurology, San Camillo Forlanini Hospital, Rome, Italy.

Enrico Pampana (E)

Department of Neuroradiology, San Camillo Forlanini Hospital, Rome, Italy.

Alberto Pingi (A)

Department of Neuroradiology, San Camillo Forlanini Hospital, Rome, Italy.

Alessandro Stasolla (A)

Department of Neuroradiology, San Camillo Forlanini Hospital, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH